UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study

The New England journal of medicine, 2015-04, Vol.372 (16), p.1510-1518

2015

Volltextzugriff (PDF)

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome

Rheumatology international, 2022-01, Vol.42 (1), p.101-113

2022

Volltextzugriff (PDF)

Post-COVID-19 vaccination inflammatory syndrome: A case report

Modern rheumatology case reports, 2023-01, Vol.7 (1), p.280

2023

Volltextzugriff (PDF)

Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome

The New England journal of medicine, 2019-11, Vol.381 (20), p.1918-1928

2019

Volltextzugriff (PDF)

Characterization of the Divergent Wound-Healing Responses Occurring in the Pathergy Reaction and Normal Healthy Volunteers

Journal of Immunology, 2006-11, Vol.177 (9), p.6415-6421

2006

Volltextzugriff (PDF)

Atherosclerosis in Behçet's Syndrome

Seminars in arthritis and rheumatism, 2008-08, Vol.38 (1), p.1-12

2008

Volltextzugriff (PDF)

Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course

Rheumatology (Oxford, England), 2014-11, Vol.53 (11), p.2018-2022

2014

Volltextzugriff (PDF)

Erythematous, annular, atrophic patchy lesions in bilateral axillae

Clinical and experimental dermatology, 2024-06

2024

Volltextzugriff (PDF)

Major vessel involvement in Behçetʼs disease: an update

Current opinion in rheumatology, 2011-01, Vol.23 (1), p.24-31

2011

Volltextzugriff (PDF)

Infliximab does not suppress the tuberculin skin test (purified protein derivative)

Journal of rheumatology, 2007-03, Vol.34 (3), p.474

2007

Volltextzugriff (PDF)

Increased arterial stiffness and accelerated atherosclerosis in Takayasu arteritis

Seminars in arthritis and rheumatism, 2023-06, Vol.60, p.152199-152199, Article 152199

2023

Volltextzugriff (PDF)

Clinical course of acute deep vein thrombosis of the legs in Behçet’s syndrome

Rheumatology (Oxford, England), 2020-04, Vol.59 (4), p.799-806

2020

Volltextzugriff (PDF)

RARE CARDIAC PRESENTATION OF WEGENER GRANULOMATOSIS AS STERILE VEGETATION

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.3231

2022

Volltextzugriff (PDF)

Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study

Rheumatic & musculoskeletal diseases open, 2022-07, Vol.8 (2), p.e002235

2022

Volltextzugriff (PDF)

Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients

Medicine (Baltimore), 2012-01, Vol.91 (1), p.35-48

2012

Volltextzugriff (PDF)

Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behçet's syndrome?

Annals of the rheumatic diseases, 2022-03, Vol.81 (3), p.448

2022

Volltextzugriff (PDF)

Long term follow-up of Behçet’s syndrome patients treated with cyclophosphamide

Rheumatology (Oxford, England), 2020-09, Vol.59 (9), p.2264-2271

2020

Volltextzugriff (PDF)

Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review

Zeitschrift für Rheumatologie, 2024-01

2024

Volltextzugriff (PDF)

De novo manifestations during adalimumab treatment in Behçet’s syndrome

Rheumatology (Oxford, England), 2024-08

2024

Volltextzugriff (PDF)

Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic review

Rheumatology (Oxford, England), 2022-12, Vol.62 (1), p.9-18

2022

Volltextzugriff (PDF)

Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome: An Observational Study

Medicine (Baltimore), 2015-11, Vol.94 (44), p.e1899-e1899

2015

Volltextzugriff (PDF)

Infliximab for vascular involvement in Behçet's syndrome

Clinical immunology (Orlando, Fla.), 2023-08, Vol.253, p.109682-109682, Article 109682

2023

Volltextzugriff (PDF)

Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis

Rheumatology international, 2023-11, Vol.43 (11), p.2099-2106

2023

Volltextzugriff (PDF)

311. INTERFERON-ALPHA FOR THE MANAGEMENT OF LOWER eXTREMITY DEEP VEIN THROMBOSIS IN BEHÇET’S SYNDROME: A CASE SERIES

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Volltextzugriff (PDF)

A Rare Cause of AA Amyloidosis: Idiopathic Retroperitoneal Fibrosis

Journal of clinical rheumatology, 2021-12, Vol.27 (8S), p.S685

2021

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome

Post-COVID-19 vaccination inflammatory syndrome: A case report

Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome

Characterization of the Divergent Wound-Healing Responses Occurring in the Pathergy Reaction and Normal Healthy Volunteers

Atherosclerosis in Behçet's Syndrome

Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course

Erythematous, annular, atrophic patchy lesions in bilateral axillae

Major vessel involvement in Behçetʼs disease: an update

Infliximab does not suppress the tuberculin skin test (purified protein derivative)

Increased arterial stiffness and accelerated atherosclerosis in Takayasu arteritis

Clinical course of acute deep vein thrombosis of the legs in Behçet’s syndrome

RARE CARDIAC PRESENTATION OF WEGENER GRANULOMATOSIS AS STERILE VEGETATION

Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study

Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients

Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behçet's syndrome?

Long term follow-up of Behçet’s syndrome patients treated with cyclophosphamide

Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review

De novo manifestations during adalimumab treatment in Behçet’s syndrome

Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic review

Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome: An Observational Study

Infliximab for vascular involvement in Behçet's syndrome

Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis

311. INTERFERON-ALPHA FOR THE MANAGEMENT OF LOWER eXTREMITY DEEP VEIN THROMBOSIS IN BEHÇET’S SYNDROME: A CASE SERIES

A Rare Cause of AA Amyloidosis: Idiopathic Retroperitoneal Fibrosis

Suchergebnisse filtern